沉默HOXB7抑制人宫颈癌细胞系CASKI转移与增强顺铂敏感性

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (4): 532-537.

沉默HOXB7抑制人宫颈癌细胞系CASKI转移与增强顺铂敏感性

孙慧霞, 郭哲, 许静^*

南阳市中心医院妇产科, 河南南阳 473000

收稿日期:2019-07-03 修回日期:2019-12-03 出版日期:2020-04-05 发布日期:2020-04-06
通讯作者: *3111685775@qq.com

Silencing HOXB7 inhibits metastasis and increases the sensitivity to cisplatin in human cervical cancer CASKI cells

SUN Hui-xia, GUO Zhe, XU Jing^*

Department of Gynecology, Nanyang City Center Hospital, Nanyang 473000, China

Received:2019-07-03 Revised:2019-12-03 Online:2020-04-05 Published:2020-04-06
Contact: *3111685775@qq.com

摘要/Abstract

摘要： 目的探究HOXB7对人宫颈癌细胞系CASKI迁移、侵袭以及顺铂敏感性的影响。方法用免疫组化法和Western blot分析宫颈癌化疗敏感组织和化疗耐药组织中HOXB7表达。用免疫荧光法和Western blot检测CASKI细胞和宫颈癌顺铂耐药CASKI/DDP细胞中HOXB7表达。sh-HOXB7转染CASKI细胞,用Transwell小室法分析细胞的侵袭和迁移能力,用CCK-8法和流式细胞术检测细胞对顺铂敏感性的影响。结果宫颈癌化疗耐药组织以及CASKI/DDP细胞中HOXB7高表达(P＜0.001); 沉默HOXB7抑制CASKI细胞的迁移与侵袭能力(P＜0.001),促进CASKI细胞对顺铂敏感性(P＜0.001)。结论沉默HOXB7抑制宫颈癌CASKI细胞的转移并促进细胞对顺铂的敏感性。

关键词: HOXB7, 宫颈癌, 侵袭, 迁移, 顺铂耐药

Abstract: Objective To explore the effect of HOXB7 on migration, invasion and the sensitivity to cisplatin in cervical cancer CASKI cells. Methods The expression level of HOXB7 in chemotherapy sensitive tissues and chemotherapy resistant tissues was detected by immunohistochemistry and Western blot. The expression level of HOXB7 in CASKI cells and cisplatin-resistant CASKI/DDP cells was detected by immunofluorescence and Western blot. sh-HOXB7 was transfected into CASKI cells and the cell invasion and migration were analyzed by transwell analysis, the sensitivity to cisplatin was detected by CCK-8 assay and flow cytometry. Results High expression of HOXB7 was found in chemoresistant tissues and CASKI/DDP cells (P＜0.001); Silencing HOXB7 inhibited migration and invasion (P＜0.001) and increased the sensitivity to cisplatin in CASKI cells (P＜0.001). Conclusions Silencing HOXB7 inhibits metastasis and increases the sensitivity to cisplatin in cervical cancer CASKI cells.

Key words: HOXB7, cervical cancer, invasion, migration, cisplatin resistance

中图分类号:

孙慧霞, 郭哲, 许静. 沉默HOXB7抑制人宫颈癌细胞系CASKI转移与增强顺铂敏感性[J]. 基础医学与临床, 2020, 40(4): 532-537.

SUN Hui-xia, GUO Zhe, XU Jing. Silencing HOXB7 inhibits metastasis and increases the sensitivity to cisplatin in human cervical cancer CASKI cells[J]. Basic & Clinical Medicine, 2020, 40(4): 532-537.

参考文献

[1]Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424.
[2]张静雅, 古力米热·布然江, 涂剑楠, 等.Ⅰb～Ⅱa期宫颈癌术后放疗后复发的相关因素分析[J]. 中国肿瘤临床, 2018, 45: 1062-1065.
[3]SShishodia G, Verma G, Das BC, et al. miRNA as viral transcription tuners in HPV-mediated cervical carcinogenesis[J]. Front Biosci (Schol Ed), 2018,10:21-47.
[4]Renou L, Boelle PY, Deswarte C, et al. Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia[J]. Blood Adv, 2017,1: 733-747.
[5]Wang WM, Xu Y, Wang YH, et al. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocel-lular carcinoma[J]. Oncotarget, 2017, 8: 47121-47135.
[6]Wu J, Long Z, Cai H, et al. Homeobox B7 accelerates the cancer progression of gastric carcinoma cells by promoting epithelial-mesenchymal transition (EMT) and activating Src-FAK pathway[J]. Onco Targets Ther, 2019, 12: 3743-3751.
[7]How C, Hui AB, Alajez NM, et al. microRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer[J]. PLoS One, 2013, 8: e67846. doi: 10.1371/journal.pone.0067846.
[8]Zhu H, Luo H, Zhang W, et al. Molecular mechanisms of cisplatin resistance in cervical cancer[J]. Drug Des Devel Ther, 2016, 10: 1885-1895.
[9]Yuan Z, Chen D, Chen X, et al. Overexpression of HOXB7 protein reduces sensitivity of oral cancer cells to chemo-radiotherapy[J]. Cancer Gene Ther, 2016, 23: 419-424.
[10]Jin K, Sukumar S. A pivotal role for HOXB7 protein in endocrine resistant breast cancer[J]. Oncoscience, 2015, 2: 917-919.
[11]Huo XY, Zhang XY, Yuan F, et al. HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/β-catenin pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23: 2476-2485.
[12]Zhong Y, Zhang Y, Ma D, et al. Inhibition of HOXB7 suppresses p27-mediated acute lymphoblastic leukemia by regulating basic fibroblast growth factor and ERK1/2[J]. Life Sci, 2019, 218: 1-7.
[13]Dai L, Hu W, Yang Z, et al. Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis[J]. Lab Invest, 2019, 99: 736-748.
[14]Chen X, Zou H, Li H, et al. Weekly versus triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of cervical cancer: a meta-analysis[J]. Int J Gynecol Cancer, 2017, 27: 344-349.
[15]Li R, Liu GZ, Luo SY, et al. Cyclin I promotes cisplatin resistance via Cdk5 activation in cervical cancer[J]. Eur Rev Med Pharmacol Sci, 2015, 19: 4533-4541.
[16]Zhou T, Fu H, Dong B, et al. HOXB7 mediates cisplatin resistance in esophageal squamous cell carcinoma through involvement of DNA damage repair[J]. Thorac Cancer, 2019, 30. doi: 10.1111/1759-7714.13142.